{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:56:03Z","timestamp":1791053763693,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2001,1,1]],"date-time":"2001-01-01T00:00:00Z","timestamp":978307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2001,1]]},"DOI":"10.1067\/mjd.2001.109853","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T04:18:43Z","timestamp":1027570723000},"page":"28-32","source":"Crossref","is-referenced-by-count":55,"title":["Increased interleukin 5 production in eosinophilic S?zary syndrome: Regulation by interferon alfa and interleukin 12"],"prefix":"10.1067","volume":"44","author":[{"given":"Karen Rebecca","family":"Suchin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Cassin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Gottleib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shobana","family":"Sood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Cucchiara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric C.","family":"Vonderheid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain H.","family":"Rook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2001.109853_bib1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0147-0272(90)90018-L","article-title":"Mycosis fungoides and the S?zary syndrome:pathology, staging, and treatment","volume":"14","author":"Hoppe","year":"1990","journal-title":"Curr Probl Cancer"},{"key":"10.1067\/mjd.2001.109853_bib2","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1200\/JCO.1991.9.7.1298","article-title":"Mycosis fungoides and the S?ezary syndreoma review of pathogenesis, diagnosis, and therapy","volume":"9","author":"Kuzel","year":"1991","journal-title":"J Clin Oncol"},{"key":"10.1067\/mjd.2001.109853_bib3","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1001\/archderm.1996.03890350051009","article-title":"Clinical stage IA (limited patch and plaque) mycosis fungoides: a long-term outcome analysis","volume":"132","author":"Kim","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2001.109853_bib4","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/archderm.1995.01690210033005","article-title":"Prognostic factors in erythrodermic mycosis fungoides and the S?zary syndrome","volume":"131","author":"Kim","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2001.109853_bib5","doi-asserted-by":"crossref","first-page":"534","DOI":"10.7326\/0003-4819-83-4-534","article-title":"Cutaneous T-cell lymphomas: the S?zary syndrome, mycosis fungoides and related disorders","volume":"83","author":"Lutzner","year":"1975","journal-title":"Ann Intern Med"},{"key":"10.1067\/mjd.2001.109853_bib6","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1002\/1097-0142(19810601)47:11<2671::AID-CNCR2820471125>3.0.CO;2-X","article-title":"Prognostic variables in mycosis fungoides","volume":"47","author":"Green","year":"1981","journal-title":"Cancer"},{"key":"10.1067\/mjd.2001.109853_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.7326\/0003-4819-100-2-187","article-title":"Clinical staging for cutaneous T-cell lymphoma","volume":"100","author":"Lamberg","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1067\/mjd.2001.109853_bib8","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/1097-0142(19881015)62:8<1658::AID-CNCR2820620834>3.0.CO;2-J","article-title":"Population-based estimate of survival and determinants of prognosis in patients with mycosis fungoides","volume":"62","author":"Weinstock","year":"1988","journal-title":"Cancer"},{"key":"10.1067\/mjd.2001.109853_bib9","doi-asserted-by":"crossref","first-page":"372","DOI":"10.7326\/0003-4819-109-5-372","article-title":"Histopathologic staging at initial diagnosis of mycosies fungoeides and the S?zary syndrome: definition of three distinctive prognostic groups","volume":"109","author":"Sausville","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1067\/mjd.2001.109853_bib10","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1001\/archderm.1991.01680090075007","article-title":"Prognostic clinico-pathologic factors in cutaneous T-cell lymphoma","volume":"127","author":"Marti","year":"1991","journal-title":"Arch Dermatol"},{"key":"10.1067\/mjd.2001.109853_bib11","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/BF00200538","article-title":"T cell and cytokine patterns in leprosy skin lesions","volume":"13","author":"Sieling","year":"1992","journal-title":"Springer Semin Immunopathol"},{"key":"10.1067\/mjd.2001.109853_bib12","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann","year":"1986","journal-title":"J Immunol"},{"key":"10.1067\/mjd.2001.109853_bib13","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood.V88.4.1383.bloodjournal8841383","article-title":"S?zary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon gamma receptor beta-chain)","volume":"88","author":"Dummer","year":"1996","journal-title":"Blood"},{"key":"10.1067\/mjd.2001.109853_bib14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/1523-1747.ep12611877","article-title":"Aberrant cytokine production by S?zary syndrome patients: cytokine secretion pattern resembles murine Th2 cells","volume":"99","author":"Vowels","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1067\/mjd.2001.109853_bib15","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1182\/blood.V87.6.2354.bloodjournal8762354","article-title":"Eosinophils express a functional receptor for interferon ?: inhibitory role of interferon ? on the release of mediators","volume":"87","author":"Aldebert","year":"1996","journal-title":"Blood"},{"key":"10.1067\/mjd.2001.109853_bib16","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0190-9622(89)70049-9","article-title":"Interferon alfa-2a in the treatment of cutaneous T cell lymphoma","volume":"20","author":"Olsen","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2001.109853_bib17","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0889-8588(18)30060-1","article-title":"Interferon in the treatment of cutaneous T-cell lymphoma","volume":"9","author":"Olsen","year":"1995","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1067\/mjd.2001.109853_bib18","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.4049\/jimmunol.154.3.1491","article-title":"IL-12 reverses cytokine and immune abnormalities in S?zary syndrome","volume":"154","author":"Rook","year":"1995","journal-title":"J Immunol"},{"key":"10.1067\/mjd.2001.109853_bib19","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1172\/JCI118417","article-title":"Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4 sup plus T cells","volume":"97","author":"Schandene","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1067\/mjd.2001.109853_bib20","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.4049\/jimmunol.154.10.5144","article-title":"Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12","volume":"154","author":"Warren","year":"1995","journal-title":"J Immunol"},{"key":"10.1067\/mjd.2001.109853_bib21","first-page":"131","article-title":"Cutaneous T-cell lymphoma","volume":"1","author":"Murphy","year":"1988","journal-title":"Adv Pathol"},{"key":"10.1067\/mjd.2001.109853_bib22","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1182\/blood.V94.3.902.415k23_902_908","article-title":"Interleukin-12 therapy of cutaneous T-cell lymphoma induces lesion regression and cytotoxic T-cell responses","volume":"94","author":"Rook","year":"1999","journal-title":"Blood"},{"key":"10.1067\/mjd.2001.109853_bib23","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1182\/blood.V79.12.3101.bloodjournal79123101","article-title":"Interleukin-5, eosinophils, and disease","volume":"79","author":"Sanderson","year":"1992","journal-title":"Blood"},{"key":"10.1067\/mjd.2001.109853_bib24","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1084\/jem.182.4.1169","article-title":"Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo","volume":"182","author":"Collins","year":"1995","journal-title":"J Exp Med"},{"key":"10.1067\/mjd.2001.109853_bib25","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1056\/NEJM199805283382206","article-title":"Mechanisms of disease: eosinophilia","volume":"338","author":"Rothenberg","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2001.109853_bib26","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1056\/NEJM198912283212603","article-title":"A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides","volume":"321","author":"Kaye","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2001.109853_bib27","first-page":"552","article-title":"Cytokine regulation of the growth of clonal malignant T-cells from patients with S?zary syndrome [abstract]","volume":"108","author":"Fox","year":"1997","journal-title":"J Invest Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962201779054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962201779054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T14:58:24Z","timestamp":1680533904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962201779054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,1]]}},"alternative-id":["S0190962201779054"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2001.109853","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}